NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$0.39 USD
+0.01 (2.63%)
Updated Aug 9, 2024 03:56 PM ET
After-Market: $0.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Brokerage Reports
NovaBay Pharmaceuticals, Inc. [NBY]
Reports for Purchase
Showing records 41 - 60 ( 109 total )
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
2017 2Q Financial Results Reported; 2017 $19M Revenue Guidance Affirmed; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
2017 2Q Financial Results Reported; 2017 $19M Revenue Guidance Affirmed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
2Q17 Recap - Pricing Hurt Quarter, but Guidance Maintained
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Avenova Tracker - Week Ending 7/7/2017 Holiday Noise.
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S